Targeted proteomics in Alzheimer's disease: focus on amyloid-beta. - Wikidata - awgldk - TriplyDB

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

http://www.wikidata.org/entity/Q37157835

about

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications Cerebrospinal fluid and blood biomarkers in Alzheimer's disease Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.Multimodal techniques for diagnosis and prognosis of Alzheimer's disease Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient.Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9.The use of mass spectrometry to study amyloid-β peptides.Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised.Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease.Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update.Amyloid Beta Peptides Affect Pregnenolone and Pregnenolone Sulfate Levels in PC-12 and SH-SY5Y Cells Depending on Cholesterol.

P2860

Q26995267-1B61E130-F499-48E9-AAE1-77B0F301BC3A Q27023758-FC64CB91-2014-4087-859C-67D33F200EFF Q30940227-867D52B7-60B4-49A4-BA5A-28D3AF5173D3 Q33607535-E254A8BB-78E4-45D8-ABF9-8CF5E21B7BDD Q33638748-C01EE90A-8E4B-4DF5-B2E9-9FBBE86E378C Q33881726-AB72A668-DCB2-4823-ADCA-A7D81CB03F05 Q34149524-E963DC2A-DC6B-4BDA-8833-96B899775C78 Q35610552-3AF52F8D-D5EC-4B0B-9635-187EC3FFB4B9 Q37866222-111DCCAA-87FD-47B6-98A6-0C8436878655 Q37971458-89FC7C54-941D-4FC2-B613-66BE1AD8E986 Q41907099-D31C9213-DC39-486D-AEBA-0BFF79D24D08 Q46257047-54FA939B-7280-483D-99B9-ABCE26C26231 Q46335422-EF429E2F-ED99-4097-A35C-3EACFBD2010A Q47932570-508493E9-7EB5-467A-B513-4CCCDB190B75 Q53137779-935BA3BD-BED9-42B7-B663-32782FAC9129

P2860

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

http://www.wikidata.org/entity/Q37157835

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

@en

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

@nl

type

label

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

@en

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

@nl

prefLabel

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

@en

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

@nl

P1433

Q37157835-61F0B2E0-D92E-4DD6-9775-9AFED8432C84

P1476

Q37157835-7E097368-7A05-484F-9221-14B47AF0636D

P2093

Q37157835-1B0BC186-127A-4ED5-AE21-D5107D2BEBE2

Q37157835-E6EEA456-396E-412F-8BA2-110D1727FC3F

P2860

Q37157835-012896E6-3F09-4351-8EE4-415D533F6291

Q37157835-04BF1D91-7EA3-43F9-94E5-1F3FE31317F0

Q37157835-17C4D39E-6F74-4C28-B54F-EC72A7F7322A

Q37157835-18B4CF07-9974-4C35-99F4-D336F5E4728E

Q37157835-1D049DFE-2ABD-4043-88E3-597889DB9739

Q37157835-1DA9A687-1DFB-4A4A-97FF-1C14BC557F7A

Q37157835-2023C015-DF89-4AEC-B09D-BE22AD01885D

Q37157835-2165D83D-4312-4ECD-BE25-DB7731F5D1CC

Q37157835-23AF9E87-819D-4A39-AF15-75DDF7B3451C

Q37157835-2996D1B1-DAC0-4060-9455-572E9F569DB4

P304

Q37157835-434689DA-9255-42A1-899C-68DF8E96BBBB

P31

Q37157835-1B3087DD-5420-4235-8E7E-D62B518DDB6B

P356

Q37157835-CEDDC054-3D27-48CF-9E28-1A24E487275C

P433

Q37157835-7FCF148A-A619-4C12-B5C4-97837ED22F7F

P478

Q37157835-CAE9ABB3-2EB6-4A38-BC08-F4C6A708209D

P50

Q37157835-22ADD864-72C1-454A-991C-BF7801BB8A99

Q37157835-29313F5C-4DCA-43EE-8034-0669AB69AB07

Q37157835-6AEB6B9B-8A20-4990-A05F-639F4E51AD4E

P577

Q37157835-BBC837AF-AC48-4067-AC17-6F726C37014C

P698

Q37157835-62DCA423-F4E0-4AB2-8736-26119CE78E2F

P921

Q37157835-B14899EC-B69A-47EA-B303-D6E6DE148C9E

P356

14789450.5.2.225

P1433

Expert Review of Proteomics

P1476

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.

@en

P2093

Johan Gobom

http://www.w3.org/2001/XMLSchema#string

Ulf Andreasson

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

Purification and cloning of amyloid precursor protein beta-secretase from human brain

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo

BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein

Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

A specific amyloid-beta protein assembly in the brain impairs memory

P304

225-237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14789450.5.2.225

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18466053

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease